Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 143

1.

Molecular Mechanisms of p63-Mediated Squamous Cancer Pathogenesis.

Moses MA, George AL, Sakakibara N, Mahmood K, Ponnamperuma RM, King KE, Weinberg WC.

Int J Mol Sci. 2019 Jul 23;20(14). pii: E3590. doi: 10.3390/ijms20143590. Review.

2.

Intersection of the p63 and NF-κB pathways in epithelial homeostasis and disease.

King KE, George AL, Sakakibara N, Mahmood K, Moses MA, Weinberg WC.

Mol Carcinog. 2019 Sep;58(9):1571-1580. doi: 10.1002/mc.23081. Epub 2019 Jul 8.

PMID:
31286584
3.

Effect of Acute Aerobic Exercise and Rapamycin Treatment on Autophagy in Peripheral Blood Mononuclear Cells of Adults With Prediabetes.

McCormick JJ, King KE, Dokladny K, Mermier CM.

Can J Diabetes. 2019 Apr 16. pii: S1499-2671(18)30997-3. doi: 10.1016/j.jcjd.2019.04.005. [Epub ahead of print]

PMID:
31213408
4.

Intrathecal enzyme replacement for Hurler syndrome: biomarker association with neurocognitive outcomes.

Eisengart JB, Pierpont EI, Kaizer AM, Rudser KD, King KE, Pasquali M, Polgreen LE, Dickson PI, Le SQ, Miller WP, Tolar J, Orchard PJ, Lund TC.

Genet Med. 2019 Apr 25. doi: 10.1038/s41436-019-0522-1. [Epub ahead of print]

PMID:
31019279
5.

Attention and corpus callosum volumes in individuals with mucopolysaccharidosis type I.

King KE, Rudser KD, Nestrasil I, Kovac V, Delaney KA, Wozniak JR, Mueller BA, Lim KO, Eisengart JB, Mamak EG, Raiman J, Ali N, Cagle S, Harmatz P, Whitley CB, Shapiro EG.

Neurology. 2019 May 14;92(20):e2321-e2328. doi: 10.1212/WNL.0000000000007496. Epub 2019 Apr 12.

PMID:
30979856
6.

The Effect of Acute Glutamine Supplementation on Markers of Inflammation and Fatigue During Consecutive Days of Simulated Wildland Firefighting.

Nava RC, Zuhl MN, Moriarty TA, Amorim FT, Bourbeau KC, Welch AM, McCormick JJ, King KE, Mermier CM.

J Occup Environ Med. 2019 Feb;61(2):e33-e42. doi: 10.1097/JOM.0000000000001507.

PMID:
30489352
7.

Transfusion of leukoreduced blood products and risk of antibody-mediated rejection of renal allografts.

Bynum JP, Zachary A, Ness PM, Luo X, Bagnasco S, King KE, Segev DL, Orandi BJ, Warren DS, Fuller A, Ciappi A, Montgomery R, Tobian AAR.

Transfusion. 2018 Aug;58(8):1951-1957. doi: 10.1111/trf.14800. Epub 2018 Sep 1.

PMID:
30171817
8.

Inhibiting Epidermal Growth Factor Receptor Dimerization and Signaling Through Targeted Delivery of a Juxtamembrane Domain Peptide Mimic.

Gerhart J, Thévenin AF, Bloch E, King KE, Thévenin D.

ACS Chem Biol. 2018 Sep 21;13(9):2623-2632. doi: 10.1021/acschembio.8b00555. Epub 2018 Aug 31.

PMID:
30133245
9.

Post-transplant adaptive function in childhood cerebral adrenoleukodystrophy.

Pierpont EI, McCoy E, King KE, Ziegler RS, Shanley R, Nascene D, Raymond GV, Phelan R, Lund TC, Orchard PJ, Miller WP.

Ann Clin Transl Neurol. 2018 Jan 22;5(3):252-261. doi: 10.1002/acn3.526. eCollection 2018 Mar.

10.

Techniques to Optimize Color Esthetics, Bonding, and Peri-implant Tissue Health With Titanium Implant Abutments.

Wadhwani CPK, Schoenbaum T, King KE, Chung KH.

Compend Contin Educ Dent. 2018 Feb;39(2):110-119.

PMID:
29388785
11.

Comparison of lipid-dependent bilayer insertion of pHLIP and its P20G variant.

Vasquez-Montes V, Gerhart J, King KE, Thévenin D, Ladokhin AS.

Biochim Biophys Acta Biomembr. 2018 Feb;1860(2):534-543. doi: 10.1016/j.bbamem.2017.11.006. Epub 2017 Nov 11.

12.

Can a documentary increase help-seeking intentions in men? A randomised controlled trial.

King KE, Schlichthorst M, Spittal MJ, Phelps A, Pirkis J.

J Epidemiol Community Health. 2018 Jan;72(1):92-98. doi: 10.1136/jech-2017-209502. Epub 2017 Nov 3.

13.

Blood Product Utilization Among Trauma and Nontrauma Massive Transfusion Protocols at an Urban Academic Medical Center.

Patel EU, Ness PM, Marshall CE, Gniadek T, Efron DT, Miller PM, Zeitouni JA, King KE, Bloch EM, Tobian AAR.

Anesth Analg. 2017 Sep;125(3):967-974. doi: 10.1213/ANE.0000000000002253.

PMID:
28719428
14.

A Cumulative Deficit Laboratory Test-based Frailty Index: Personal and Neighborhood Associations.

King KE, Fillenbaum GG, Cohen HJ.

J Am Geriatr Soc. 2017 Sep;65(9):1981-1987. doi: 10.1111/jgs.14983. Epub 2017 Jun 30.

15.

Perfect storm: Therapeutic plasma exchange for a patient with thyroid storm.

McGonigle AM, Tobian AAR, Zink JL, King KE.

J Clin Apher. 2018 Feb;33(1):113-116. doi: 10.1002/jca.21560. Epub 2017 Jun 13.

PMID:
28608527
16.

Cardiotoxicity of ErbB2-targeted therapies and its impact on drug development, a spotlight on trastuzumab.

Dokmanovic M, King KE, Mohan N, Endo Y, Wu WJ.

Expert Opin Drug Metab Toxicol. 2017 Jul;13(7):755-766. doi: 10.1080/17425255.2017.1337746. Epub 2017 Jun 9. Review.

PMID:
28571477
17.

Outcomes and risk stratification for late antibody-mediated rejection in recipients of ABO-incompatible kidney transplants: a retrospective study.

Lonze BE, Bae S, Kraus ES, Holechek MJ, King KE, Alachkar N, Naqvi FF, Dagher NN, Sharif A, Desai NM, Segev DL, Montgomery RA.

Transpl Int. 2017 Sep;30(9):874-883. doi: 10.1111/tri.12969. Epub 2017 Jun 2.

18.

A rare, potentially life-threatening presentation of passenger lymphocyte syndrome.

Gniadek TJ, McGonigle AM, Shirey RS, Brunker PA, Streiff M, Philosophe B, Bloch EM, Ness PM, King KE.

Transfusion. 2017 May;57(5):1262-1266. doi: 10.1111/trf.14055. Epub 2017 Mar 28.

PMID:
28369969
19.

Blood product utilization in human upper-extremity transplantation: challenges, complications, considerations, and transfusion protocol conception.

Raval JS, Gorantla VS, Shores JT, Lee WP, Planinsic RM, Rollins-Raval MA, Brandacher G, King KE, Losee JE, Kiss JE.

Transfusion. 2017 Mar;57(3):606-612. doi: 10.1111/trf.14009.

PMID:
28297082
20.

Maternal blood lead concentrations, DNA methylation of MEG3 DMR regulating the DLK1/MEG3 imprinted domain and early growth in a multiethnic cohort.

Nye MD, King KE, Darrah TH, Maguire R, Jima DD, Huang Z, Mendez MA, Fry RC, Jirtle RL, Murphy SK, Hoyo C.

Environ Epigenet. 2016;2(1). pii: dvv009. doi: 10.1093/eep/dvv009. Epub 2016 Feb 15.

21.

Transition metal oxide nanoparticles as surfaces for surface-assisted laser desorption/ionization mass spectrometry of asphaltenes.

Olaitan AD, Reyes KA, Barnes LF, Yount JR, Ward S, Hamilton HSC, King KE, Van Leeuwen CJ, Stepherson JR, Vargas TK, Kirkconnell MP, Molek KS.

Pet Sci Technol. 2017;35(19):1917-1924. doi: 10.1080/10916466.2017.1370476. Epub 2017 Nov 28.

22.

High-dose Cyclophosphamide is Effective Therapy for Pediatric Severe Aplastic Anemia.

Gamper CJ, Takemoto CM, Chen AR, Symons HJ, Loeb DM, Casella JF, Dezern AE, King KE, McGonigle AM, Jones RJ, Brodsky RA.

J Pediatr Hematol Oncol. 2016 Nov;38(8):627-635.

23.

Use of hydroxyethyl starch in leukocytapheresis procedures does not increase renal toxicity.

Pagano MB, Harmon C, Cooling L, Connelly-Smith L, Mann SA, Pham HP, Marques MB, Schlueter AJ, Case R, King KE, Cataife G, Wu Y, Wong EC, Winters JL.

Transfusion. 2016 Nov;56(11):2848-2856. doi: 10.1111/trf.13795. Epub 2016 Sep 7.

24.

Advanced Virus Detection Technologies Interest Group (AVDTIG): Efforts on High Throughput Sequencing (HTS) for Virus Detection.

Khan AS, Vacante DA, Cassart JP, Ng SH, Lambert C, Charlebois RL, King KE.

PDA J Pharm Sci Technol. 2016 11/12;70(6):591-595. Epub 2016 Sep 4.

PMID:
27593693
25.

Platelet corrected count increments by apheresis platform.

Tobian AA, King KE, Borge PD, Fuller AK, Uglik K, Ness PM.

Transfusion. 2016 Oct;56(10):2584-2586. doi: 10.1111/trf.13788. Epub 2016 Aug 29.

PMID:
27572682
26.

Red blood cell transfusion triggers in acute leukemia: a randomized pilot study.

DeZern AE, Williams K, Zahurak M, Hand W, Stephens RS, King KE, Frank SM, Ness PM.

Transfusion. 2016 Jul;56(7):1750-7. doi: 10.1111/trf.13658. Epub 2016 May 20. Erratum in: Transfusion. 2016 Dec;56(12 ):3150.

27.

Prognostic risk-stratified score for predicting mortality in hospitalized patients with thrombotic thrombocytopenic purpura: nationally representative data from 2007 to 2012.

Goel R, King KE, Takemoto CM, Ness PM, Tobian AA.

Transfusion. 2016 Jun;56(6):1451-8. doi: 10.1111/trf.13586. Epub 2016 Apr 15.

28.

Neighborhood and Family Environment of Expectant Mothers May Influence Prenatal Programming of Adult Cancer Risk: Discussion and an Illustrative DNA Methylation Example.

King KE, Kane JB, Scarbrough P, Hoyo C, Murphy SK.

Biodemography Soc Biol. 2016;62(1):87-104. doi: 10.1080/19485565.2015.1126501.

29.

Therapeutic plasma exchange for kidney transplantation: the problem of antibody-mediated rejection.

King KE, Montgomery RA.

Transfusion. 2015 Apr;55(4):696-9. doi: 10.1111/trf.13068. No abstract available.

PMID:
26840785
31.

Geographic clustering of elevated blood heavy metal levels in pregnant women.

King KE, Darrah TH, Money E, Meentemeyer R, Maguire RL, Nye MD, Michener L, Murtha AP, Jirtle R, Murphy SK, Mendez MA, Robarge W, Vengosh A, Hoyo C.

BMC Public Health. 2015 Oct 9;15:1035. doi: 10.1186/s12889-015-2379-9.

32.

Efficacy of transfusion with granulocytes from G-CSF/dexamethasone-treated donors in neutropenic patients with infection.

Price TH, Boeckh M, Harrison RW, McCullough J, Ness PM, Strauss RG, Nichols WG, Hamza TH, Cushing MM, King KE, Young JA, Williams E, McFarland J, Holter Chakrabarty J, Sloan SR, Friedman D, Parekh S, Sachais BS, Kiss JE, Assmann SF.

Blood. 2015 Oct 29;126(18):2153-61. doi: 10.1182/blood-2015-05-645986. Epub 2015 Sep 2.

33.

Pre-radiation lymphocyte harvesting and post-radiation reinfusion in patients with newly diagnosed high grade gliomas.

Campian JL, Ye X, Gladstone DE, Ambady P, Nirschl TR, Borrello I, Golightly M, King KE, Holdhoff M, Karp J, Drake CG, Grossman SA.

J Neurooncol. 2015 Sep;124(2):307-16. doi: 10.1007/s11060-015-1841-y. Epub 2015 Jun 13.

34.

Hypotensive transfusion reactions in the era of prestorage leukoreduction.

Pagano MB, Ness PM, Chajewski OS, King KE, Wu Y, Tobian AA.

Transfusion. 2015 Jul;55(7):1668-74. doi: 10.1111/trf.13047. Epub 2015 Mar 3.

PMID:
25731668
35.

Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality.

Goel R, Ness PM, Takemoto CM, Krishnamurti L, King KE, Tobian AA.

Blood. 2015 Feb 26;125(9):1470-6. doi: 10.1182/blood-2014-10-605493. Epub 2015 Jan 14.

36.

The future of red blood cell alloimmunization risk reduction.

Kacker S, Ness PM, Shirey RS, Savage WJ, King KE, Tobian AA.

Transfusion. 2015 Jan;55(1):222-4. doi: 10.1111/trf.12866. No abstract available.

37.

Dr. King responds to "history of place, life course, and health inequalities".

King KE.

Am J Epidemiol. 2015 Jan 1;181(1):30-1. doi: 10.1093/aje/kwu315. Epub 2014 Nov 19. No abstract available.

PMID:
25414160
38.
39.

The evaluation of a new apheresis device for automated red blood cell exchange procedures in patients with sickle cell disease.

Quirolo K, Bertolone S, Hassell K, Howard T, King KE, Rhodes DK, Bill J.

Transfusion. 2015 Apr;55(4):775-81. doi: 10.1111/trf.12891. Epub 2014 Oct 21.

PMID:
25330984
40.

Economic evaluation of a hypothetical screening assay for alloimmunization risk among transfused patients with sickle cell disease.

Kacker S, Ness PM, Savage WJ, Frick KD, Shirey RS, King KE, Tobian AA.

Transfusion. 2014 Aug;54(8):2034-44. doi: 10.1111/trf.12585. Epub 2014 Feb 27.

41.

Efficacy of therapeutic plasma exchange for treatment of stiff-person syndrome.

Pagano MB, Murinson BB, Tobian AA, King KE.

Transfusion. 2014 Jul;54(7):1851-6. doi: 10.1111/trf.12573. Epub 2014 Feb 17. Review.

PMID:
24527774
42.

Pharmacological analysis of dopamine modulation in the Drosophila melanogaster larval heart.

Titlow JS, Rufer JM, King KE, Cooper RL.

Physiol Rep. 2013 Jul;1(2):e00020. doi: 10.1002/phy2.20. Epub 2013 Jun 26.

43.

The impact of platelet additive solution apheresis platelets on allergic transfusion reactions and corrected count increment (CME).

Tobian AA, Fuller AK, Uglik K, Tisch DJ, Borge PD, Benjamin RJ, Ness PM, King KE.

Transfusion. 2014 Jun;54(6):1523-9; quiz 1522. doi: 10.1111/trf.12498. Epub 2013 Nov 19.

44.

The association of health and income in the elderly: experience from a southern state of Brazil.

Fillenbaum GG, Blay SL, Pieper CF, King KE, Andreoli SB, Gastal FL.

PLoS One. 2013 Sep 13;8(9):e73930. doi: 10.1371/journal.pone.0073930. eCollection 2013.

45.

First FDA approval of dual anti-HER2 regimen: pertuzumab in combination with trastuzumab and docetaxel for HER2-positive metastatic breast cancer.

Blumenthal GM, Scher NS, Cortazar P, Chattopadhyay S, Tang S, Song P, Liu Q, Ringgold K, Pilaro AM, Tilley A, King KE, Graham L, Rellahan BL, Weinberg WC, Chi B, Thomas C, Hughes P, Ibrahim A, Justice R, Pazdur R.

Clin Cancer Res. 2013 Sep 15;19(18):4911-6. doi: 10.1158/1078-0432.CCR-13-1212. Epub 2013 Jun 25.

46.

Delineating Molecular Mechanisms of Squamous Tissue Homeostasis and Neoplasia: Focus on p63.

King KE, Ha L, Camilli T, Weinberg WC.

J Skin Cancer. 2013;2013:632028. doi: 10.1155/2013/632028. Epub 2013 Apr 22.

47.

Cost-effectiveness of prospective red blood cell antigen matching to prevent alloimmunization among sickle cell patients.

Kacker S, Ness PM, Savage WJ, Frick KD, Shirey RS, King KE, Tobian AA.

Transfusion. 2014 Jan;54(1):86-97. doi: 10.1111/trf.12250. Epub 2013 May 21.

48.

Innovations in primary mental healthcare.

Reifels L, Bassilios B, King KE, Fletcher JR, Blashki G, Pirkis JE.

Aust Health Rev. 2013 Jun;37(3):312-7. doi: 10.1071/AH12203.

PMID:
23601705
49.

Spontaneous splenic rupture during induction chemotherapy for acute myeloid leukemia.

Zeidan AM, Mitchell M, Khatri R, Itani D, Boikos S, Bose S, Lipsett P, Efron D, King KE, Gerber J, DeZern A.

Leuk Lymphoma. 2014 Jan;55(1):209-12. doi: 10.3109/10428194.2013.796060. Epub 2013 Jun 5. No abstract available.

50.

Red blood cell alloimmunization: lessons from sickle cell disease.

Treml A, King KE.

Transfusion. 2013 Apr;53(4):692-5. doi: 10.1111/trf.12146. No abstract available.

PMID:
23565994

Supplemental Content

Loading ...
Support Center